Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Celldex Therapeutics, Inc.

US, Hampton [HQ]

CIK 1709113

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

12,610

Price per Share :

$22.62

Equivalence :

$285,238.20

Transaction History

M

Form 4

12,610 Shares After Transaction

Value : $35,055.80

$29,885.00

Transaction Date : 05/30/24
- Footnotes
- Form 4
Footnotes:
#1 Includes 576 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.

#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.465 to $34.06 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
M

Form 4

22,713 Shares After Transaction

Value : $204,871.26

$91,129.06

Transaction Date : 05/30/24
- Footnotes
- Form 4
Footnotes:
#1 Includes 576 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.

#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.465 to $34.06 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
S

Form 4

1,860 Shares After Transaction

Value : $62,737.80

Sold $703,371.69

Transaction Date : 05/30/24
- Footnotes
- Form 4
Footnotes:
#1 Includes 576 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.

#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.465 to $34.06 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.